Wallman Richard F's Form 4 filing
Charles River Laboratories International, Inc. (CRL) · filed Feb 23, 2022
- Accession no.
- 0001127602-22-006257
- Filed
- Feb 23, 2022
- Trade date
- Feb 18-22, 2022
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $2.11M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wallman Richard FCIK 0001198092 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2022 | Common Stock | SSaleDisposed | −2,800 | $297.50 | −$833,000 | 3,250 | Indirect | |
| Feb 18, 2022 | Common Stock | SSaleDisposed | −425 | $295.00 | −$125,375 | 18,404 | Direct | |
| Feb 18, 2022 | Common Stock | SSaleDisposed | −725 | $295.00 | −$213,875 | 17,679 | Direct | |
| Feb 22, 2022 | Common Stock | SSaleDisposed | −3,250 | $288.05 | −$936,162.5 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.